X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/mira-pharmaceuticals-announces-ketamir-2-shows-promising-safety-profile-in-comparison-to-traditional-ketamine-in-preclinical-testing-302179730.html
https://www.prnewswire.com/news-releases/mira-pharmaceuticals-announces-dea-rules-mira-55-a-novel-oral-pharmaceutical-marijuana-analog-is-not-classified-as-a-controlled-substance-302158026.html
https://www.prnewswire.com/news-releases/mira-pharmaceuticals-in-discussions-with-memorial-sloan-kettering-to-collaborate-on-preclinical-cancer-pain-model-utilizing-the-companys-novel-oral-ketamine-analog-302151004.html
https://www.prnewswire.com/news-releases/mira-pharmaceuticals-announces-encouraging-preclinical-results-advancing-ketamir-2-towards-potential-year-end-ind-submission-302105198.html
https://www.prnewswire.com/news-releases/mira-pharmaceuticals-welcomes-dr-itzchak-angel-former-head-of-pharmacology-at-synthelabo-as-chief-scientific-advisor-302096130.html
https://www.indianpharmapost.com/news/mira-pharmaceuticals-announces-collaboration-with-pharmaseed-15249
https://www.prnewswire.com/news-releases/mira-pharmaceuticals-provides-corporate-update-302052883.html
https://www.prnewswire.com/news-releases/mira-pharmaceuticals-releases-breakthrough-data-from-artificial-intelligence-simulations-302004158.html
https://www.mirapharmaceuticals.com/investors/news-events/press-releases/detail/90/mira-pharmaceuticals-announces-ketamir-2s-oral
Market Place
Share 
